Peptron, Inc. (087010.KQ)
KRW 98300.0
(-1.99%)
KRW 98300.0
(-1.99%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -15.6 Billion KRW | -9.06% |
| 2022 | -15.78 Billion KRW | 4.62% |
| 2021 | -16.54 Billion KRW | 10.48% |
| 2020 | -18.48 Billion KRW | -39.45% |
| 2019 | -13.25 Billion KRW | -67.66% |
| 2018 | -7.9 Billion KRW | -65.6% |
| 2017 | -4.77 Billion KRW | -33.94% |
| 2016 | -3.56 Billion KRW | -25.05% |
| 2015 | -2.85 Billion KRW | -9.23% |
| 2014 | -2.6 Billion KRW | -34.43% |
| 2013 | -1.94 Billion KRW | -46.76% |
| 2012 | -1.32 Billion KRW | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -4.27 Billion KRW | -4.36% |
| 2024 Q1 | -4.09 Billion KRW | -26.32% |
| 2023 Q4 | -3.24 Billion KRW | 22.44% |
| 2023 Q1 | -4.18 Billion KRW | 23.03% |
| 2023 Q3 | -4.18 Billion KRW | 25.29% |
| 2023 Q2 | -5.6 Billion KRW | -33.89% |
| 2023 FY | -17.21 Billion KRW | -9.06% |
| 2022 Q4 | -5.43 Billion KRW | -44.23% |
| 2022 Q3 | -3.76 Billion KRW | 14.88% |
| 2022 Q2 | -4.42 Billion KRW | -105.43% |
| 2022 Q1 | -2.15 Billion KRW | 53.89% |
| 2022 FY | -15.78 Billion KRW | 4.62% |
| 2021 Q3 | -4.69 Billion KRW | -157.49% |
| 2021 Q1 | -5.35 Billion KRW | -4.1% |
| 2021 FY | -16.54 Billion KRW | 10.48% |
| 2021 Q2 | -1.82 Billion KRW | 66.01% |
| 2021 Q4 | -4.67 Billion KRW | 0.4% |
| 2020 Q1 | -3.7 Billion KRW | -15.25% |
| 2020 FY | -18.48 Billion KRW | -39.45% |
| 2020 Q4 | -5.14 Billion KRW | -17.09% |
| 2020 Q3 | -4.39 Billion KRW | -1.02% |
| 2020 Q2 | -4.35 Billion KRW | -17.41% |
| 2019 Q3 | -3.86 Billion KRW | -17.19% |
| 2019 Q2 | -3.3 Billion KRW | -42.38% |
| 2019 FY | -13.25 Billion KRW | -67.66% |
| 2019 Q1 | -2.31 Billion KRW | -20.27% |
| 2019 Q4 | -3.21 Billion KRW | 16.83% |
| 2018 Q1 | -1.46 Billion KRW | -5.06% |
| 2018 Q3 | -2.6 Billion KRW | -36.1% |
| 2018 FY | -7.9 Billion KRW | -65.6% |
| 2018 Q4 | -1.92 Billion KRW | 25.87% |
| 2018 Q2 | -1.91 Billion KRW | -30.19% |
| 2017 Q3 | -1 Billion KRW | 7.04% |
| 2017 Q2 | -1.07 Billion KRW | 16.93% |
| 2017 Q1 | -1.29 Billion KRW | -20.83% |
| 2017 FY | -4.77 Billion KRW | -33.94% |
| 2017 Q4 | -1.39 Billion KRW | -39.41% |
| 2016 Q3 | -833.9 Million KRW | -5.56% |
| 2016 Q1 | -866.51 Million KRW | -8.84% |
| 2016 FY | -3.56 Billion KRW | -25.05% |
| 2016 Q2 | -789.98 Million KRW | 8.83% |
| 2016 Q4 | -1.07 Billion KRW | -28.77% |
| 2015 Q3 | -780.7 Million KRW | -0.97% |
| 2015 FY | -2.85 Billion KRW | -9.23% |
| 2015 Q4 | -796.15 Million KRW | -1.98% |
| 2015 Q2 | -773.19 Million KRW | -54.59% |
| 2015 Q1 | -500.14 Million KRW | 0.0% |
| 2014 FY | -2.6 Billion KRW | -34.43% |
| 2014 Q2 | -561.11 Million KRW | 24.84% |
| 2014 Q1 | -746.58 Million KRW | 0.0% |
| 2014 Q3 | -646.91 Million KRW | -15.29% |
| 2013 FY | -1.94 Billion KRW | -46.76% |
| 2012 FY | -1.32 Billion KRW | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HLB Co., Ltd. | -125.02 Billion KRW | 87.52% |
| iNtRON Biotechnology, Inc. | -3.28 Billion KRW | -374.981% |
| BINEX Co., Ltd. | 1.04 Billion KRW | 1597.023% |
| Bioneer Corporation | 791.75 Million KRW | 2070.681% |
| Anterogen.Co.,Ltd. | -5.07 Billion KRW | -207.517% |
| MEDIPOST Co., Ltd. | -25.13 Billion KRW | 37.913% |
| CrystalGenomics, Inc. | -30.91 Billion KRW | 49.526% |
| Helixmith Co., Ltd | -35.24 Billion KRW | 55.731% |
| Chabiotech Co.,Ltd. | -9.42 Billion KRW | -65.545% |
| Medy-Tox Inc. | 17.32 Billion KRW | 190.074% |
| Amicogen, Inc. | 2.05 Billion KRW | 858.845% |
| Genexine, Inc. | -41.24 Billion KRW | 62.166% |
| HLB Therapeutics Co.,Ltd. | -8.7 Billion KRW | -79.339% |
| LegoChem Biosciences, Inc. | -80.82 Billion KRW | 80.695% |
| ALTEOGEN Inc. | -9.73 Billion KRW | -60.246% |
| PharmaResearch Co., Ltd. | 100.81 Billion KRW | 115.476% |
| SillaJen, Inc. | -21.34 Billion KRW | 26.904% |
| JETEMA, Co., Ltd. | 2.63 Billion KRW | 692.447% |
| OliX Pharmaceuticals,Inc | -18.18 Billion KRW | 14.201% |
| Genomictree Inc. | -17.3 Billion KRW | 9.828% |
| MedPacto, Inc. | -28.75 Billion KRW | 45.733% |
| D&D Pharmatech | -13.48 Billion KRW | -15.695% |
| EASY BIO,Inc. | 20.63 Billion KRW | 175.628% |
| GI Innovation, Inc. | -55.6 Billion KRW | 71.939% |